Frontmatter

Artikel in diesem Heft

1. Frontmatter
2. Editorial
3. Liquid profiling – circulating nucleic acid diagnostics gains momentum
4. Articles
5. The rising tide of cell-free DNA profiling: from snapshot to temporal genome analysis
6. Liquid profiling for cancer patient stratification in precision medicine – current status and challenges for successful implementation in standard care
7. Status of liquid profiling in precision oncology – the need for integrative diagnostics for successful implementation into standard care
8. Pan-cancer screening by circulating tumor DNA (ctDNA) – recent breakthroughs and chronic pitfalls
9. Multimodality in liquid biopsy: does a combination uncover insights undetectable in individual blood analytes?
10. Circulating cell-free DNA and its clinical utility in cancer
11. Are extracellular vesicles ready for the clinical laboratory?
12. Profiling disease and tissue-specific epigenetic signatures in cell-free DNA
13. Cell-free DNA in sports medicine: implications for clinical laboratory medicine
14. Clonal hematopoiesis of indeterminate potential: clinical relevance of an incidental finding in liquid profiling
15. Non-invasive prenatal screening tests – update 2022
16. The DKTK EXLIQUID consortium – exploiting liquid biopsies to advance cancer precision medicine for molecular tumor board patients